Comparison

Capivasertib European Partner

Item no. TMO-T1920-2mg
Manufacturer TargetMol
CASRN 1143532-39-1
Amount 2 mg
Quantity options 100 mg 1 mL x 10 mM (in DMSO) 10 mg 1 mg 1 mL 200 mg 25 mg 2 mg 500 mg 50 mg 5 mg
Category
Type Molecules
Specific against other
Purity 0,9948
Citations 1. Addie M, et al. J Med Chem, 2013, 26.
Smiles NC1(CCN(CC1)c1ncnc2[nH]ccc12)C(=O)N[C@@H](CCO)c1ccc(Cl)cc1
ECLASS 10.1 32169090
ECLASS 11.0 32169090
UNSPSC 12000000
Alias AZD5363
Shipping Condition Cool pack
Available
Manufacturer - Targets
Akt|||PKA|||mTOR|||Autophagy
Shipping Temperature
Cool pack
Storage Conditions
-20
Molecular Weight
428.92
Description
Capivasertib (AZD5363) is a broad-spectrum AKT inhibitor with inhibitory activity against Akt1, Akt2, and Akt3 (IC50=3/7/7 nM) with oral activity. Capivasertib has antitumor activity for the treatment of breast cancer.
Pathways
PI3K/Akt/mTOR signaling|||Tyrosine Kinase/Adaptors|||Autophagy|||Cytoskeletal Signaling

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 2 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close